France· FR:69494932
PYOSTACINE 250 mg, comprimé pelliculé
A pristinamycin product containing pristinamycine, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Pristinamycin is registered in 3 of 19 countries.
Countries holding a registration under ATC J01FG01 (pristinamycin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Pristinamycin · ATC J01FG01
3 / 19 countries
- Franceprice
- Norwayprice
- United Kingdom
Price per daily dose
What a daily dose of pristinamycin costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- France: $5.16 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Pristinamycin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- FR France$5.16
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PRISTINAMYCINE
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- J01FG01
- ATC class
- Pristinamycin
- Defined daily dose
- 2 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933937218plaquette(s) PVC-Aluminium de 16 comprimé(s)EUR 9.09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pristinamycin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b297b0d8-c3ad-4998-b5ec-66d80c5200e2 GET /v1/drugs/b297b0d8-c3ad-4998-b5ec-66d80c5200e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69494932",
"date_amm": "1995-08-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PRISTINAMYCINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about pristinamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.